July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
The dysregulation of interphotoreceptor retinoid binding protein (IRBP) under hyperglycemic conditions in Akita mice and human retinal explant culture
Author Affiliations & Notes
  • Shaoxue Zeng
    Department of opthalmology, Sichuan University, Chengdu, China
    Save Sight Institute, Sydney University, New South Wales, Australia
  • Ting Zhang
    Save Sight Institute, Sydney University, New South Wales, Australia
  • Ling Zhu
    Save Sight Institute, Sydney University, New South Wales, Australia
  • Weiyong Shen
    Save Sight Institute, Sydney University, New South Wales, Australia
  • Junjun Zhang
    Department of opthalmology, Sichuan University, Chengdu, China
  • Mark Gilles
    Save Sight Institute, Sydney University, New South Wales, Australia
  • Footnotes
    Commercial Relationships   Shaoxue Zeng, None; Ting Zhang, None; Ling Zhu, None; Weiyong Shen, None; Junjun Zhang, None; Mark Gilles, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 2670. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Shaoxue Zeng, Ting Zhang, Ling Zhu, Weiyong Shen, Junjun Zhang, Mark Gilles; The dysregulation of interphotoreceptor retinoid binding protein (IRBP) under hyperglycemic conditions in Akita mice and human retinal explant culture. Invest. Ophthalmol. Vis. Sci. 2019;60(9):2670.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Interphotoreceptor retinoid-binding protein (IRBP) is an essential photoreceptor-specific protein responsible for the solubilisation and transport of retinoids between the retinal pigment epithelium and photoreceptors in the eye. Functional IRBP is critical for the survival of photoreceptors. We previously found that photoreceptor degeneration is preceded by a marked reduction of IRBP expression in a murine model of retinal degeneration. We believe this pathogenic progress occurs in most types of retinal stress such as that induced by hyperglycemia (diabetes). Therefore, we studied the dysregulation of IRBP under hyperglycemic conditions, both ex vivoand in vivo.

Methods : We compared the retinal expression level of IRBP in Akita mice (a model of diabetes) to control C57bl/6 mice using Western blot. The location and intensity of IRBP expression was determined by immunofluorescence staining on frozen sections of the Akita and control mice. We further evaluated expression levels of IRBP in human retinal explants cultured with different concentrations of glucose.

Results : There was significant down-regulation of IRBP (83% of the control level) in the retinas of Akita mice compared with those from C57bl/6 control mice. Immunofluorescent staining revealed that IRBP was primarily down-regulated in the inner and outer segments of the retinas of the Akita mice when compared with retinas of control mice. This down regulation was also observed in the human retinal explants cultured with high concentrations of glucose. A high glucose treatment (45mM D-Glucose) significantly reduced the expression of IRBP (49% of the control level) compared with the control treatment (5.5mM D-Glucose).

Conclusions : Hyperglycemia induces the down-regulation of IRBP expression in photoreceptors of mice and the human retina. This may contribute to the pathogenesis of diabetic retinopathy. Further studies of signaling pathways which regulate the expression of IRBP under hyperglycemic conditions are needed to affirm this hypothesis.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×